Mutual Funds Sahi Hai!
To avail the service, you will be redirected to loans.geojitcredits.com
In Q1 FY26, operating EBITDA stood at Rs 330 crore, up 13%, compared with Rs 292 crore posted in the same quarter last year. Operating EBITDA margin stood at 30.2% in Q1 FY26 as against 29% in Q1 FY25.
Nikhil Chopra, CEO and whole-time director of JB Pharma, stated, “JB continues to be the fastest-growing domestic pharma company amongst the top 25 organizations as per IQVIA MAT Jun’25 data. The domestic business recorded approximately 14% value growth. This was driven by acute and chronic segments, including our ophthalmology portfolio.
Our major brands & their franchises are also performing well. The CDMO business momentum is likely to be sustained in coming quarters. Our operating EBITDA margins crossed 30% for the first time, which highlights the results of our strategy of focusing on profitable growth.
Going forward, we will maintain focus on driving topline growth, cost optimization, and organizational efficiencies. I am confident that the organization will continue to perform well, with our domestic and CDMO segments leading the way on growth and profitability. We have all the necessary building blocks in place for sustainable growth in the coming years.”
JB Chemicals & Pharmaceuticals manufactures a wide range of pharmaceutical formulation specialties, radiodiagnostics, APIs, and intermediates.
Shares of JB Chemicals & Pharmaceuticals fell 1.67% to Rs 1,753.15 on the BSE.
J B Chemicals & Pharmaceuticals Ltd is up for a fifth straight session in a row. The stock is quoting at Rs 1713.7, up 1.07% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is down around 0.79% on the day, quoting at 24864.7. The Sensex is at 81608.67, down 0.7%. J B Chemicals & Pharmaceuticals Ltd has slipped around 2.2% in last one month.
Meanwhile, Nifty Pharma index of which J B Chemicals & Pharmaceuticals Ltd is a constituent, has slipped around 3.59% in last one month and is currently quoting at 22541.05, up 0.22% on the day. The volume in the stock stood at 2.26 lakh shares today, compared to the daily average of 5.17 lakh shares in last one month.
The PE of the stock is 41.83 based on TTM earnings ending March 25.